GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai ZJ Bio-Tech Co Ltd (SHSE:688317) » Definitions » 5-Year Yield-on-Cost %

Shanghai ZJ Bio-Tech Co (SHSE:688317) 5-Year Yield-on-Cost % : 0.59 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai ZJ Bio-Tech Co 5-Year Yield-on-Cost %?

Shanghai ZJ Bio-Tech Co's yield on cost for the quarter that ended in Sep. 2024 was 0.59.


The historical rank and industry rank for Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:688317' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.59   Med: 4.09   Max: 8.47
Current: 0.59


During the past 11 years, Shanghai ZJ Bio-Tech Co's highest Yield on Cost was 8.47. The lowest was 0.59. And the median was 4.09.


SHSE:688317's 5-Year Yield-on-Cost % is ranked worse than
85.49% of 317 companies
in the Medical Devices & Instruments industry
Industry Median: 2.05 vs SHSE:688317: 0.59

Competitive Comparison of Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost % falls into.



Shanghai ZJ Bio-Tech Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shanghai ZJ Bio-Tech Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shanghai ZJ Bio-Tech Co  (SHSE:688317) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shanghai ZJ Bio-Tech Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shanghai ZJ Bio-Tech Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai ZJ Bio-Tech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
Executives
Ni Wei Qin Directors, senior managers
Shao Jun Bin Directors, senior managers, core technical personn
Zhu Qin Wei Core technical personnel
Lv Li Lang senior management

Shanghai ZJ Bio-Tech Co Headlines

No Headlines